Rxsight, Inc. 8-K Filing
Ticker: RXST · Form: 8-K · Filed: Dec 19, 2025 · CIK: 1111485
| Field | Detail |
|---|---|
| Company | Rxsight, Inc. (RXST) |
| Form Type | 8-K |
| Filed Date | Dec 19, 2025 |
| Pages | 1 |
| Reading Time | 2 min |
| Key Dollar Amounts | $0.001 |
| Sentiment | neutral |
Sentiment: neutral
FAQ
What type of filing is this?
This is a 8-K filing submitted by Rxsight, Inc. (ticker: RXST) to the SEC on Dec 19, 2025.
What are the key financial figures in this filing?
Key dollar amounts include: $0.001 (ch registered Common Stock, par value $0.001 per share RXST The Nasdaq Stock Mar).
How long is this filing?
Rxsight, Inc.'s 8-K filing is 1 pages with approximately 439 words. Estimated reading time is 2 minutes.
Where can I view the full 8-K filing?
The complete filing is available on SEC EDGAR. You can also read the AI-decoded analysis with risk assessment and key highlights on ReadTheFiling.
Filing Stats: 439 words · 2 min read · ~1 pages · Grade level 11.3 · Accepted 2025-12-19 16:15:25
Key Financial Figures
- $0.001 — ch registered Common Stock, par value $0.001 per share RXST The Nasdaq Stock Mar
Filing Documents
- rxst-20251218.htm (8-K) — 41KB
- 0001193125-25-326889.txt ( ) — 140KB
- rxst-20251218.xsd (EX-101.SCH) — 23KB
- rxst-20251218_htm.xml (XML) — 4KB
SIGNATURES
SIGNATURES Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned thereunto duly authorized. RxSight, Inc. Date: December 19, 2025 By: /s/ Ron Kurtz, M.D. Ron Kurtz, M.D. Chief Executive Officer and President